NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
10.62
+0.02 (0.19%)
Oct 28, 2025, 4:00 PM EDT - Market closed

NeuroPace Statistics

Total Valuation

NeuroPace has a market cap or net worth of $351.33 million. The enterprise value is $360.70 million.

Market Cap351.33M
Enterprise Value 360.70M

Important Dates

The next confirmed earnings date is Tuesday, November 4, 2025, after market close.

Earnings Date Nov 4, 2025
Ex-Dividend Date n/a

Share Statistics

NeuroPace has 33.08 million shares outstanding. The number of shares has increased by 12.50% in one year.

Current Share Class 33.08M
Shares Outstanding 33.08M
Shares Change (YoY) +12.50%
Shares Change (QoQ) +4.39%
Owned by Insiders (%) 3.64%
Owned by Institutions (%) 53.30%
Float 22.52M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.71
Forward PS 3.48
PB Ratio 18.05
P/TBV Ratio 18.07
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.07
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.47, with a Debt / Equity ratio of 3.68.

Current Ratio 5.47
Quick Ratio 4.42
Debt / Equity 3.68
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.31

Financial Efficiency

Return on equity (ROE) is -176.94% and return on invested capital (ROIC) is -14.23%.

Return on Equity (ROE) -176.94%
Return on Assets (ROA) -12.39%
Return on Invested Capital (ROIC) -14.23%
Return on Capital Employed (ROCE) -22.33%
Revenue Per Employee $481,359
Profits Per Employee -$140,989
Employee Count184
Asset Turnover 0.88
Inventory Turnover 1.55

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +67.24% in the last 52 weeks. The beta is 1.91, so NeuroPace's price volatility has been higher than the market average.

Beta (5Y) 1.91
52-Week Price Change +67.24%
50-Day Moving Average 10.02
200-Day Moving Average 11.36
Relative Strength Index (RSI) 52.95
Average Volume (20 Days) 123,241

Short Selling Information

The latest short interest is 1.08 million, so 3.28% of the outstanding shares have been sold short.

Short Interest 1.08M
Short Previous Month 1.12M
Short % of Shares Out 3.28%
Short % of Float 4.81%
Short Ratio (days to cover) 7.16

Income Statement

In the last 12 months, NeuroPace had revenue of $88.57 million and -$25.94 million in losses. Loss per share was -$0.84.

Revenue88.57M
Gross Profit 67.08M
Operating Income -19.87M
Pretax Income -25.94M
Net Income -25.94M
EBITDA -19.66M
EBIT -19.87M
Loss Per Share -$0.84
Full Income Statement

Balance Sheet

The company has $62.14 million in cash and $71.52 million in debt, giving a net cash position of -$9.38 million or -$0.28 per share.

Cash & Cash Equivalents 62.14M
Total Debt 71.52M
Net Cash -9.38M
Net Cash Per Share -$0.28
Equity (Book Value) 19.44M
Book Value Per Share 0.59
Working Capital 76.60M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.09 million and capital expenditures -$344,000, giving a free cash flow of -$16.43 million.

Operating Cash Flow -16.09M
Capital Expenditures -344,000
Free Cash Flow -16.43M
FCF Per Share -$0.50
Full Cash Flow Statement

Margins

Gross margin is 75.74%, with operating and profit margins of -22.43% and -29.29%.

Gross Margin 75.74%
Operating Margin -22.43%
Pretax Margin -29.29%
Profit Margin -29.29%
EBITDA Margin -22.20%
EBIT Margin -22.43%
FCF Margin n/a

Dividends & Yields

NeuroPace does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.50%
Shareholder Yield -12.50%
Earnings Yield -7.38%
FCF Yield -4.68%

Analyst Forecast

The average price target for NeuroPace is $16.67, which is 56.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target $16.67
Price Target Difference 56.97%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 19.06%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

NeuroPace has an Altman Z-Score of -3.95 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.95
Piotroski F-Score 4